Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
MYND Life Sciences Inc
C.MYND
Alternate Symbol(s):
MYNDF
Healthcare
Biotechnology
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (CSE:MYND)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(14)
•••
SmallCapIntel
X
Post by
SmallCapIntel
on Jul 20, 2021 6:58am
3 min clip describing the 4 key patents of MYND
Honestly cant say enough how much I hope they're successful with treating and regressing Alzheimer's disease. It would legit by life changing for so many elderly people in their later years of
...more
(10)
•••
KenoCity
X
Post by
KenoCity
on Jul 09, 2021 3:01pm
Joined the Team
looking at this... this could be an amazing journey.... putting a couple of hundred a week into the MYND... instead of chasing MINE...ing stocks lol could you imagine the possibilites... wow.
...more
(14)
•••
SmallCapIntel
X
Post by
SmallCapIntel
on Jul 07, 2021 8:27am
Great corporate recap interview from their CEO
This sh*t excites the hell out of me. Coming from someone whos grandpa went through Alzhymer's, if they can treat it AND prove regression in humans (theyve done so in mice) then this is one of the
...more
(14)
•••
SmallCapIntel
X
Post by
SmallCapIntel
on Jun 23, 2021 8:53am
Now Alzheimers and Dementia lanes!
Love seeing these guys expand their psych medicine science into Alzheimer's disease and Dementia. Two incredibly sad things to happen to a human as they age. If we can find a solution to
...more
(14)
•••
SmallCapIntel
X
Post by
SmallCapIntel
on Jun 22, 2021 10:17am
This is such a sleeper psych play
I cant wait for more eyes to come onto this play. These guys are looking to change the game by having no psychoactive effects from their psilocybin drug against depression. They just need to get their
...more
(14)
•••
SmallCapIntel
X
Post by
SmallCapIntel
on Jun 10, 2021 7:26am
Boom! Patents filed and clinical trials date set
I still think this one is the most unique way of treating depression that Ive heard of yet. Looks like theyve now filed provisional patents and are aiming to start clinical trials later this year
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Environmental technology company enters a new strategic phase focused on scale and profitability
Mt Todd has emerged as one of the most compelling undeveloped gold assets globally